SynthesisAddiction science & clinical practice2026
Prevalence of sleep-related symptoms in patients receiving methadone maintenance treatment: a systematic review and meta-analysis.
Synthesis in Addiction science & clinical practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Prevalence of sleep-related symptoms in patients receiving methadone maintenance treatment: a systematic review and meta-analysis.Addiction science & clinical practice · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSleep disturbances are sometimes reported in clinical settings among individuals with opioid use disorder (OUD) receiving methadone maintenance treatment (MMT). Although numerous studies have explored this issue, a systematic assessment of the prevalence of these disturbances is lacking.
methodsWe searched for trials reporting the prevalence of sleep disturbances in patients with OUD receiving MMT. Studies assessing sleep-related symptoms using a standardized scale were included in a prevalence meta-analysis. All other studies were synthesized narratively and in tabular form.
resultsThirty-eight articles were included. Thirteen studies assessed the prevalence of poor sleep quality using a Pittsburgh Sleep Quality Index (PSQI) score > 5. Given the high level of heterogeneity among included studies, a prediction interval was calculated, suggesting that the prevalence of poor sleepers in future trials will likely range from 50% to 93%. The weighted prevalence estimate of poor sleepers was 75% (95% CI [61-85%], τ² = 1.34). Sensitivity analyses were performed to investigate heterogeneity among the included studies. Eight of the thirteen studies were rated as having low risk of bias, and the certainty of evidence was found to be moderate. In the narrative synthesis, the reported prevalence of daytime sleepiness ranged from 15% to 50%. In studies using polysomnography or nocturnal polygraphy, patients exhibited significantly reduced sleep efficiency and a high prevalence of sleep apnea syndrome, ranging from 39.1% to 78.3%.
conclusionsOur findings indicate that patients receiving MMT often experience poor sleep quality, highlighting the need for systematic attention to sleep issues while taking into account psychosocial vulnerability. REGISTRATION: CRD42025649687. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.